Literature DB >> 15665219

Imaging of macrophages in soft-tissue infection in rats: relationship between ultrasmall superparamagnetic iron oxide dose and MR signal characteristics.

Amelie M Lutz1, Dominik Weishaupt, Elke Persohn, Kerstin Goepfert, Johannes Froehlich, Bernd Sasse, Jochen Gottschalk, Borut Marincek, Achim H Kaim.   

Abstract

PURPOSE: To describe dose-dependent signal intensity (SI) characteristics of experimentally induced soft-tissue abscesses on 1.5-T T1- and T2*-weighted magnetic resonance (MR) images obtained 24 hours after administration of ultrasmall superparamagnetic iron oxide (USPIO) and to describe the relationship between SI and amount of USPIO uptake and macrophage iron content.
MATERIALS AND METHODS: Local institutional review committee on animal care approved the experiments, which were performed according to the guidelines of the National Institutes of Health and the committee on animal research at our institution. Unilateral calf muscle abscesses were induced in 21 rats with an injection of a Staphylococcus aureus suspension. The rats were divided into three groups of seven animals each: low USPIO dose (50 micromol of iron per kilogram of body weight), high USPIO dose (150 micromol Fe/kg), and control (saline solution). All rats were imaged before and 24 hours after USPIO administration at 1.5 T (transverse T1-weighted spin-echo, T2*-weighted fast gradient-echo, and short inversion time inversion-recovery sequences). Images were analyzed quantitatively and qualitatively with regard to SI and signal pattern. Temporal variation of calculated contrast-to-noise ratios was analyzed with the Wilcoxon signed rank test. MR findings were correlated with histopathologic findings, including those of electron microscopy.
RESULTS: Twenty-four hours after USPIO administration in the high-dose group, susceptibility effects were present in abscess periphery on postcontrast T2*-weighted images (P=.04), and SI enhancement was noted on postcontrast T1-weighted images within both abscess wall and abscess center (P=.04 for both). In the low-dose group, SI enhancement was noted in entire abscess on T1-weighted postcontrast images (P=.03). Neither significant SI loss (P=.09) nor susceptibility effects were detected in periphery or center of any abscess on postcontrast T2*-weighted images. There was no obvious difference in total amount of macrophages among the groups, but there was a clear difference with regard to individual iron content of iron-positive macrophages between the USPIO dose groups.
CONCLUSION: At 1.5 T, SI characteristics of abscesses on T1- and T2*-weighted images obtained 24 hours after USPIO injection strongly depend on administered dose of the contrast agent. At low doses, T1 effects were stronger than T2* effects.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15665219     DOI: 10.1148/radiol.2343031172

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  17 in total

1.  USPIO-enhanced magnetic resonance imaging of the knee in asymptomatic volunteers.

Authors:  C S Reiner; A M Lutz; F Tschirch; J M Froehlich; S Gaillard; B Marincek; D Weishaupt
Journal:  Eur Radiol       Date:  2009-03-28       Impact factor: 5.315

2.  MR imaging enables measurement of therapeutic nanoparticle uptake in rat N1-S1 liver tumors after nanoablation.

Authors:  Joseph L McDevitt; Samdeep K Mouli; Patrick D Tyler; Weiguo Li; Jodi Nicolai; Daniele Procissi; Ann B Ragin; Y Andrew Wang; Robert J Lewandowski; Riad Salem; Andrew C Larson; Reed A Omary
Journal:  J Vasc Interv Radiol       Date:  2014-05-20       Impact factor: 3.464

3.  T1 and T2 relaxivity of intracellular and extracellular USPIO at 1.5T and 3T clinical MR scanning.

Authors:  Gerhard H Simon; Jan Bauer; Olaf Saborovski; Yanjun Fu; Claire Corot; Michael F Wendland; Heike E Daldrup-Link
Journal:  Eur Radiol       Date:  2005-11-25       Impact factor: 5.315

4.  Fluorochrome-functionalized nanoparticles for imaging DNA in biological systems.

Authors:  Hoonsung Cho; David Alcantara; Hushan Yuan; Rahul A Sheth; Howard H Chen; Peng Huang; Sean B Andersson; David E Sosnovik; Umar Mahmood; Lee Josephson
Journal:  ACS Nano       Date:  2013-02-07       Impact factor: 15.881

5.  USPIO-enhanced MRI of highly invasive and highly metastasizing transplanted human squamous cell carcinoma: an experimental study.

Authors:  A Tetsumura; S Nakamura; N Yoshino; H Watanabe; A Kuribayashi; K Nagumo; N Okada; T Sasaki; T Kurabayashi
Journal:  Dentomaxillofac Radiol       Date:  2011-11-24       Impact factor: 2.419

Review 6.  Iron-based superparamagnetic nanoparticle contrast agents for MRI of infection and inflammation.

Authors:  Alexander Neuwelt; Navneet Sidhu; Chien-An A Hu; Gary Mlady; Steven C Eberhardt; Laurel O Sillerud
Journal:  AJR Am J Roentgenol       Date:  2015-03       Impact factor: 3.959

7.  Pace of macrophage recruitment during different stages of soft tissue infection: semi-quantitative evaluation by in vivo magnetic resonance imaging.

Authors:  Jin Seong Lee; Jin Young Sohn; Hyun-Don Jung; Sang-Tae Kim; Kyoung Geun Lee; Hee Jung Kang
Journal:  Eur Radiol       Date:  2008-05-06       Impact factor: 5.315

8.  MRI confirms loss of blood-brain barrier integrity in a mouse model of disseminated candidiasis.

Authors:  Dhammika H M L P Navarathna; Jeeva Munasinghe; Martin J Lizak; Debasis Nayak; Dorian B McGavern; David D Roberts
Journal:  NMR Biomed       Date:  2013-04-22       Impact factor: 4.044

9.  Visualizing implanted tumors in mice with magnetic resonance imaging using magnetotactic bacteria.

Authors:  Michael R Benoit; Dirk Mayer; Yoram Barak; Ian Y Chen; Wei Hu; Zhen Cheng; Shan X Wang; Daniel M Spielman; Sanjiv S Gambhir; A Matin
Journal:  Clin Cancer Res       Date:  2009-08-11       Impact factor: 12.531

10.  Macrophage imaging by USPIO-enhanced MR for the differentiation of infectious osteomyelitis and aseptic vertebral inflammation.

Authors:  Guillaume Bierry; François Jehl; Nelly Boehm; Philippe Robert; Jean-Louis Dietemann; Stéphane Kremer
Journal:  Eur Radiol       Date:  2009-02-06       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.